How These Arrowhead Research Corporation (ARWR) Bets Paid Off

Arrowhead Research Corp (ARWR) is diving on an FDA decision

Digital Content Group
Jan 12, 2015 at 10:31 AM
facebook X logo linkedin


Arrowhead Research Corp (NASDAQ:ARWR) is plunging this morning -- down nearly 28% to trade at $6.55 -- after the Food and Drug Administration (FDA) asked the pharmaceutical firm to reduce the dosage of its hepatitis B drug in a mid-stage trial, and placed the treatment on partial clinical hold. This is likely music to the ears of option bears, who were especially active on Friday.

Diving right in, puts crossed the tape at almost six times the average daily rate last Friday. ARWR's most active option was the January 2015 9-strike put, where 1,130 contracts changed hands -- a number of which were bought to open. In short, these traders are gambling on the shares to end this week -- when front-month options expire -- below breakeven at $8.47, or the strike less the volume-weighted average price (VWAP) of $0.53.

Given this morning's sell-off, the January 9 puts are now safely in the money. What's more, the buyers are already staring at paper profits, based on the option's current VWAP of $2.41.

Taking a step back, Arrowhead Research Corp (NASDAQ:ARWR) -- which landed on the short-sale restricted (SSR) list out of the gate -- has seen a rush of bearish betting in recent months. During the last 50 days at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), the stock has tallied a put/call volume ratio of 0.49 -- just 9 percentage points shy of an annual high. Additionally, 31.5% of ARWR's float is sold short, and it would take more than a week to buy back these shorted shares, at typical daily trading volumes.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI